PIK3CA and neoplasm: The clinical relevance of PIK3CA mutations has been extensively studied and is thought to be associated with favorable clinicopathological factors, such as smaller tumor size, HR positivity, and lower grade (Loi, et al. 2013; Sabine et al. 2014; Zardavas et al. 2018).